The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
HOOKIPA Pharma Inc(NASDAQ:HOOK) 
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II cli...
Website: http://www.hookipapharma.com
Founded: 2011
Full Time Employees: 85
CEO: Jörn Aldag
Sector: Healthcare
Industry: Biotechnology
HOOKIPA Pharma Days Payable Outstanding ttm (DPO)
HOOKIPA Pharma Days Receivable Outstanding ttm (DSO)
HOOKIPA Pharma Op Cashflow Per Share ttm
HOOKIPA Pharma Free Cashflow Per Share ttm
HOOKIPA Pharma Cash Per Share ttm
HOOKIPA Pharma P/S ratio ttm
HOOKIPA Pharma (GAAP) P/E ratio ttm
HOOKIPA Pharma P/B ratio ttm
No extra charts and metrics for this ticker.